8 Results for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Standards
|
|
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatmentsNICE Guidance, 2024Copyrights: © NICE 2024 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 2 |
Material Type: Standards
|
|
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 3 |
Material Type: Standards
|
|
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin geneNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 4 |
Material Type: Standards
|
|
Ponesimod for treating relapsing–remitting multiple sclerosisNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 5 |
Material Type: Standards
|
|
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 6 |
Material Type: Standards
|
|
Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitisNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 7 |
Material Type: Standards
|
|
Tocilizumab for treating giant cell arteritisNICE Guidance, 2018Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 8 |
Material Type: Standards
|
|
Ceritinib for untreated ALK-positive non-small-cell lung cancerNICE Guidance, 2018Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2018 (1)
- 2018 To 2018 (2)
- 2019 To 2021 (1)
- 2022 To 2023 (4)
- After 2023 (1)
-
More options
Subject
- Marketing (7)
- Clinical Practice Guidelines (7)
- Clinical Trials (5)
- Chemotherapy (4)
- Clinical Medicine (4)
- Patients (3)
- Leukemia (2)
- Cancer Therapies (2)
- Mutation (2)
- Steroids (2)
- Cholangiocarcinoma (1)
- Agreements (1)
- Acids (1)
- Decision Making (1)
- Alliances (1)
- Cataracts (1)
- Bone Marrow (1)
-
More options
Databases
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||